Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.961 EUR | +8.58% | -4.56% | -49.31% |
Apr. 04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
Apr. 03 | AB Science: reconsideration possible for masitinib in ALS | CF |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- AB Stock
- A8D Stock
- Revisions AB Science